skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure of the apo anti-influenza CH65 Fab

; ;  [1]
  1. (Scripps)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
National Institutes of Health (NIH)
OSTI Identifier:
Resource Type:
Journal Article
Resource Relation:
Journal Name: Acta Crystallogr. F; Journal Volume: 71; Journal Issue: (2) ; 02, 2015
Country of Publication:
United States

Citation Formats

Lee, Peter S., Arnell, Ashley J., and Wilson, Ian A. Structure of the apo anti-influenza CH65 Fab. United States: N. p., 2015. Web. doi:10.1107/S2053230X14027599.
Lee, Peter S., Arnell, Ashley J., & Wilson, Ian A. Structure of the apo anti-influenza CH65 Fab. United States. doi:10.1107/S2053230X14027599.
Lee, Peter S., Arnell, Ashley J., and Wilson, Ian A. 2015. "Structure of the apo anti-influenza CH65 Fab". United States. doi:10.1107/S2053230X14027599.
title = {Structure of the apo anti-influenza CH65 Fab},
author = {Lee, Peter S. and Arnell, Ashley J. and Wilson, Ian A.},
abstractNote = {},
doi = {10.1107/S2053230X14027599},
journal = {Acta Crystallogr. F},
number = (2) ; 02, 2015,
volume = 71,
place = {United States},
year = 2015,
month = 2
  • M2 is one of the most conserved influenza proteins, and has been widely prospected as a potential universal vaccine target, with protection predominantly mediated by antibodies. In this paper we describe the creation of a humanized single chain Fv from 14C2, a potent monoclonal antibody against M2. We show that the humanized scFv demonstrates similar activity to the parental mAb: it is able to recognize M2 in its native context on cell surfaces and is able to show protective in vitro activity against influenza, and so represents a potential lead antibody candidate for universal prophylactic or therapeutic intervention in influenza.
  • ABS>The action of ionizing radiations on the capability of the white mouse organism to elaborate virus neutralizing antibodies was studied. The mice were subjected to gamma irradiation for 12 weeks of their growth period at doses of 1, 2, and 3 r per day. Total doses consisted of 84, 168, and 252 r, respectively. The mice were given live vaccine against type A/sub 2/ influenza virus. A decrease in the capability of the experimental animals to elaborate antibodies in comparison with the controls was evident following all three irradiation doses. (OTS)
  • The humoral response to influenza A/PR8 virus was examined in the CAB/N and C/sub 3/J.xid strains of mice, both of which bear an X-linked genetic defect (xid), and in strains lacking this defect. Hemagglutination-inhibiting antibody titers and measurement of virus-specific antibodies by solid-phase radioimmunoassay indicated that the xid defect does not impair the production of an adequate anti-influenza antibody response. However, investigation of the isotopes of PR8 virus-specific antibodies disclosed a relative decrease in the levels of IgG3 and IgG1 in the xid-bearing strains. This was observed after both intraperitoneal immunization and aerosol infection. The isotope differences were not reflectedmore » in the susceptibility of these strains to influenza virus infection.« less
  • Studies were undertaken to define the helper T-cell requirements for in vitro specific antibody production to influenza virus. Subpopulations of human T cells were separated on the basis of their reactivity with the monoclonal antibody OKT4. B cells cultured with OKT4+ T cells produced specific antibody to influenza virus, while B cells cultured with OKT4- T cells did not. Irradiation (1200 rads) of the OKT4- subset to potentially eliminate suppressor-cell activity did not augment the helper-cell function of that subset. Thus, unlike the cytotoxic T-cell response to influenza, help for an in vitro antibody response is mediated only by OKT4+more » T cells.« less